drugset / Trial / NCT00626639
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy
RandomizedParallel-groupDouble-blindSupportive care
Summary
Oral Mucositis associated with adjuvant radiation and concurrent chemotherapy in postoperative Head and Neck setting
Timeline
- Start
- 2005-07
- Primary completion
- 2007-05
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palifermin | Protein / enzyme biologic | 120 ug/kg | Intravenous |
| Background | Cisplatin | Other / unclassified | 100 mg/m2 | Intravenous |